Ingalls & Snyder LLC’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-300
Closed -$11K 417
2020
Q2
$11K Hold
300
﹤0.01% 399
2020
Q1
$7K Hold
300
﹤0.01% 405
2019
Q4
$12K Hold
300
﹤0.01% 397
2019
Q3
$13K Hold
300
﹤0.01% 419
2019
Q2
$15K Hold
300
﹤0.01% 423
2019
Q1
$14K Buy
+300
New +$18.2K ﹤0.01% 412
2017
Q1
Sell
-1,800
Closed -$86K 417
2016
Q4
$86K Hold
1,800
﹤0.01% 391
2016
Q3
$117K Hold
1,800
0.01% 394
2016
Q2
$83K Buy
+1,800
New +$72.5K ﹤0.01% 408

Other funds holding NUS

Ingalls & Snyder LLC's NUS Position: Q4 2023 in Review

Ingalls & Snyder LLC sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 10,882 shares — an estimated $231K sold.

Ingalls & Snyder LLC first reported a position in NUS in Q3 2014 and held it in 37 quarters. The position peaked at $6.07M in Q1 2015. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.

  • Ingalls & Snyder LLC reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 10,882 Nu Skin shares in Q4 2023, an estimated $231K.
  • Ingalls & Snyder LLC first reported a position in Nu Skin in Q3 2014 and held it in 37 quarters.
  • Ingalls & Snyder LLC's Nu Skin position peaked at $6.07M in Q1 2015.
  • 212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2023, filed 29 Jan 2024.